Cargando…
A human protein hydroxylase that accepts D-residues
Factor inhibiting hypoxia-inducible factor (FIH) is a 2-oxoglutarate-dependent protein hydroxylase that catalyses C3 hydroxylations of protein residues. We report FIH can accept (D)- and (L)-residues for hydroxylation. The substrate selectivity of FIH differs for (D) and (L) epimers, e.g., (D)- but...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814778/ https://www.ncbi.nlm.nih.gov/pubmed/36703414 http://dx.doi.org/10.1038/s42004-020-0290-5 |
_version_ | 1784864212629061632 |
---|---|
author | Choi, Hwanho Hardy, Adam P. Leissing, Thomas M. Chowdhury, Rasheduzzaman Nakashima, Yu Ge, Wei Markoulides, Marios Scotti, John S. Gerken, Philip A. Thorbjornsrud, Helen Kang, Dahye Hong, Sungwoo Lee, Joongoo McDonough, Michael A. Park, Hwangseo Schofield, Christopher J. |
author_facet | Choi, Hwanho Hardy, Adam P. Leissing, Thomas M. Chowdhury, Rasheduzzaman Nakashima, Yu Ge, Wei Markoulides, Marios Scotti, John S. Gerken, Philip A. Thorbjornsrud, Helen Kang, Dahye Hong, Sungwoo Lee, Joongoo McDonough, Michael A. Park, Hwangseo Schofield, Christopher J. |
author_sort | Choi, Hwanho |
collection | PubMed |
description | Factor inhibiting hypoxia-inducible factor (FIH) is a 2-oxoglutarate-dependent protein hydroxylase that catalyses C3 hydroxylations of protein residues. We report FIH can accept (D)- and (L)-residues for hydroxylation. The substrate selectivity of FIH differs for (D) and (L) epimers, e.g., (D)- but not (L)-allylglycine, and conversely (L)- but not (D)-aspartate, undergo monohydroxylation, in the tested sequence context. The (L)-Leu-containing substrate undergoes FIH-catalysed monohydroxylation, whereas (D)-Leu unexpectedly undergoes dihydroxylation. Crystallographic, mass spectrometric, and DFT studies provide insights into the selectivity of FIH towards (L)- and (D)-residues. The results of this work expand the potential range of known substrates hydroxylated by isolated FIH and imply that it will be possible to generate FIH variants with altered selectivities. |
format | Online Article Text |
id | pubmed-9814778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-98147782023-01-10 A human protein hydroxylase that accepts D-residues Choi, Hwanho Hardy, Adam P. Leissing, Thomas M. Chowdhury, Rasheduzzaman Nakashima, Yu Ge, Wei Markoulides, Marios Scotti, John S. Gerken, Philip A. Thorbjornsrud, Helen Kang, Dahye Hong, Sungwoo Lee, Joongoo McDonough, Michael A. Park, Hwangseo Schofield, Christopher J. Commun Chem Article Factor inhibiting hypoxia-inducible factor (FIH) is a 2-oxoglutarate-dependent protein hydroxylase that catalyses C3 hydroxylations of protein residues. We report FIH can accept (D)- and (L)-residues for hydroxylation. The substrate selectivity of FIH differs for (D) and (L) epimers, e.g., (D)- but not (L)-allylglycine, and conversely (L)- but not (D)-aspartate, undergo monohydroxylation, in the tested sequence context. The (L)-Leu-containing substrate undergoes FIH-catalysed monohydroxylation, whereas (D)-Leu unexpectedly undergoes dihydroxylation. Crystallographic, mass spectrometric, and DFT studies provide insights into the selectivity of FIH towards (L)- and (D)-residues. The results of this work expand the potential range of known substrates hydroxylated by isolated FIH and imply that it will be possible to generate FIH variants with altered selectivities. Nature Publishing Group UK 2020-05-01 /pmc/articles/PMC9814778/ /pubmed/36703414 http://dx.doi.org/10.1038/s42004-020-0290-5 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Choi, Hwanho Hardy, Adam P. Leissing, Thomas M. Chowdhury, Rasheduzzaman Nakashima, Yu Ge, Wei Markoulides, Marios Scotti, John S. Gerken, Philip A. Thorbjornsrud, Helen Kang, Dahye Hong, Sungwoo Lee, Joongoo McDonough, Michael A. Park, Hwangseo Schofield, Christopher J. A human protein hydroxylase that accepts D-residues |
title | A human protein hydroxylase that accepts D-residues |
title_full | A human protein hydroxylase that accepts D-residues |
title_fullStr | A human protein hydroxylase that accepts D-residues |
title_full_unstemmed | A human protein hydroxylase that accepts D-residues |
title_short | A human protein hydroxylase that accepts D-residues |
title_sort | human protein hydroxylase that accepts d-residues |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814778/ https://www.ncbi.nlm.nih.gov/pubmed/36703414 http://dx.doi.org/10.1038/s42004-020-0290-5 |
work_keys_str_mv | AT choihwanho ahumanproteinhydroxylasethatacceptsdresidues AT hardyadamp ahumanproteinhydroxylasethatacceptsdresidues AT leissingthomasm ahumanproteinhydroxylasethatacceptsdresidues AT chowdhuryrasheduzzaman ahumanproteinhydroxylasethatacceptsdresidues AT nakashimayu ahumanproteinhydroxylasethatacceptsdresidues AT gewei ahumanproteinhydroxylasethatacceptsdresidues AT markoulidesmarios ahumanproteinhydroxylasethatacceptsdresidues AT scottijohns ahumanproteinhydroxylasethatacceptsdresidues AT gerkenphilipa ahumanproteinhydroxylasethatacceptsdresidues AT thorbjornsrudhelen ahumanproteinhydroxylasethatacceptsdresidues AT kangdahye ahumanproteinhydroxylasethatacceptsdresidues AT hongsungwoo ahumanproteinhydroxylasethatacceptsdresidues AT leejoongoo ahumanproteinhydroxylasethatacceptsdresidues AT mcdonoughmichaela ahumanproteinhydroxylasethatacceptsdresidues AT parkhwangseo ahumanproteinhydroxylasethatacceptsdresidues AT schofieldchristopherj ahumanproteinhydroxylasethatacceptsdresidues AT choihwanho humanproteinhydroxylasethatacceptsdresidues AT hardyadamp humanproteinhydroxylasethatacceptsdresidues AT leissingthomasm humanproteinhydroxylasethatacceptsdresidues AT chowdhuryrasheduzzaman humanproteinhydroxylasethatacceptsdresidues AT nakashimayu humanproteinhydroxylasethatacceptsdresidues AT gewei humanproteinhydroxylasethatacceptsdresidues AT markoulidesmarios humanproteinhydroxylasethatacceptsdresidues AT scottijohns humanproteinhydroxylasethatacceptsdresidues AT gerkenphilipa humanproteinhydroxylasethatacceptsdresidues AT thorbjornsrudhelen humanproteinhydroxylasethatacceptsdresidues AT kangdahye humanproteinhydroxylasethatacceptsdresidues AT hongsungwoo humanproteinhydroxylasethatacceptsdresidues AT leejoongoo humanproteinhydroxylasethatacceptsdresidues AT mcdonoughmichaela humanproteinhydroxylasethatacceptsdresidues AT parkhwangseo humanproteinhydroxylasethatacceptsdresidues AT schofieldchristopherj humanproteinhydroxylasethatacceptsdresidues |